Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 29
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Bausch Health Companies Inc
BHC
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$6.92
0.61
9.67%
Ult. Agg.: Oct 28, 7:55 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
PRO
Perché si muove?:
Bausch Health shares are trading higher after the company reported better-t...
Utili:
I risultati di Q3 2026 sono stati pubblicati oggi dopo la chiusura del mercato.
Conference call:
La conference call di oggi è iniziata 9 ore fa
Clicca per vedere il webcast
Bausch Health Companies Financials
Bausch Health Companies (BHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.790B-$11.040B to $10.975B-$11.175B vs $10.927B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.790 billion-$11.040 billion to $10.975 billion-$11.175 billion vs $10.927 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q3 Adj. EPS $1.77 Beats $1.29 Estimate, Sales $2.941B Beat $2.757B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.29 by 37.21 percent. This is a 52.59 percent increase over earnings of $1.16 per share
Benzinga Newsdesk
Why Is Bausch + Lomb Stock Falling Monday?
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
Neeraj Jain
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share
Benzinga Newsdesk
